Zydus Lifesciences’ shares fell 6% to Rs 1,109 after acquiring a 50% stake in Sterling Biotech for Rs 550 crore. Analysts maintain neutral ratings with target prices of Rs 1,020 and Rs 1,210.
Vedanta Aluminium at earnings inflection point? Here’s why Motilal Oswal sees 21% upside
Motilal Oswal has reiterated its Buy rating on Vedanta Aluminium Metal with a target price of Rs 540, implying 21% upside. The brokerage expects EBITDA